Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

10.0%

2 terminated out of 20 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

15%

3 trials in Phase 3/4

Results Transparency

63%

5 of 8 completed with results

Key Signals

5 with results80% success

Data Visualizations

Phase Distribution

19Total
Not Applicable (12)
P 1 (1)
P 2 (3)
P 4 (3)

Trial Status

Completed8
Recruiting6
Unknown4
Terminated2

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT05414708Not ApplicableRecruiting

Art Therapy and Emotional Well Being in Military Populations With Posttraumatic Stress Symptoms

NCT06020261Not ApplicableRecruitingPrimary

Parent Management Training to Treat Irritability

NCT05388656Phase 4Completed

Estrogen Variability and Irritability During the Menopause Transition

NCT05930886Recruiting

Focus Groups in Ethnically and Racially Diverse Families

NCT03863288Phase 1TerminatedPrimary

Dose Response Relationship of Oxytocin on Irritability in Youths

NCT06505980Not ApplicableRecruiting

Stop, Focus, Plan, and Change: Predicting Parent and Child Responses to a Brief, Telehealth Parent Training

NCT06133231Not ApplicableRecruiting

Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)

NCT04776304Not ApplicableCompleted

Art Therapy QEEG Study for Service Members with a Traumatic Brain Injury and Posttraumatic Stress Symptoms

NCT03592368Not ApplicableCompletedPrimary

Hostile Interpretation Bias Training to Treat Irritability

NCT05528926Not ApplicableRecruitingPrimary

RESist Against Irritability Superiority Trial

NCT05974241Phase 4CompletedPrimary

Irritability in Children With ADHD and Emotion Dysregulation

NCT02507284Phase 2CompletedPrimary

Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease

NCT05043805Phase 4UnknownPrimary

Dextromethorphan Added on for Children With Chronic Irritability

NCT05260398Not ApplicableUnknown

Examining the Impacts on In-School Behaviors of In-Home Videogame Play

NCT00627250Not ApplicableCompletedPrimary

Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic Irritability

NCT04715932Phase 2Completed

Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN)

NCT03697837Not ApplicableCompleted

Digital Parent Training for Disruptive Behaviors in Children

NCT04635618Not ApplicableUnknown

Psychotherapy Strategies for the Treatment of Professionals and Students From Essential Services With High Levels of Emotional Distress in the Context of COVID-19

NCT01675960Phase 2Terminated

Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired Children

NCT01326663Not ApplicableUnknown

Divalproex Sodium for Mood Swings and Alcohol Use Following Head Injury.

Showing all 20 trials

Research Network

Activity Timeline